OCA

Octagon Capital Advisors Portfolio holdings

AUM $799M
1-Year Est. Return 480.2%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+480.2%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$799M
AUM Growth
+$158M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$18.4M
2
+$17.8M
3
+$17.7M
4
LXEO icon
Lexeo Therapeutics
LXEO
+$15.7M
5
BIOA
BioAge Labs
BIOA
+$14.2M

Top Sells

1
+$62.1M
2
+$29M
3
+$20.4M
4
COGT icon
Cogent Biosciences
COGT
+$14.7M
5
NUVB icon
Nuvation Bio
NUVB
+$9.74M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABVX
1
Abivax
ABVX
$9.59B
$102M 12.76%
756,000
-569,000
DNTH icon
2
Dianthus Therapeutics
DNTH
$2.39B
$99.6M 12.47%
2,416,667
COGT icon
3
Cogent Biosciences
COGT
$6.31B
$83.5M 10.45%
2,350,000
-524,111
TSHA icon
4
Taysha Gene Therapies
TSHA
$1.24B
$48.7M 6.1%
8,859,911
-207,589
GOSS icon
5
Gossamer Bio
GOSS
$98.3M
$43.1M 5.4%
13,915,371
-3,134,629
KYMR icon
6
Kymera Therapeutics
KYMR
$7.31B
$41.6M 5.21%
535,000
+175,000
AVBP icon
7
ArriVent BioPharma
AVBP
$948M
$39.7M 4.96%
1,971,054
TRVI icon
8
Trevi Therapeutics
TRVI
$1.53B
$35.2M 4.41%
2,815,000
OCUL icon
9
Ocular Therapeutix
OCUL
$1.95B
$31.9M 3.99%
2,623,600
-400
DFTX
10
Definium Therapeutics
DFTX
$1.72B
$29.9M 3.74%
2,230,000
+100,000
ALMS
11
Alumis Inc
ALMS
$3.7B
$24.7M 3.09%
+2,530,700
PALI icon
12
Palisade Bio
PALI
$264M
$22.5M 2.81%
+9,567,898
CDTX
13
DELISTED
Cidara Therapeutics
CDTX
$22.1M 2.77%
100,000
BIOA
14
BioAge Labs
BIOA
$930M
$21.1M 2.65%
+1,598,000
KALV icon
15
KalVista Pharmaceuticals
KALV
$823M
$20.6M 2.57%
1,273,333
RAPT icon
16
RAPT Therapeutics
RAPT
$1.68B
$19.4M 2.43%
+574,000
CNTA
17
Centessa Pharmaceuticals
CNTA
$3.97B
$18.8M 2.35%
750,000
-80,000
PHVS icon
18
Pharvaris
PHVS
$1.84B
$18.6M 2.33%
671,465
-51,130
LXEO icon
19
Lexeo Therapeutics
LXEO
$524M
$17.1M 2.14%
+1,725,000
BBOT
20
BridgeBio Oncology
BBOT
$802M
$13.1M 1.64%
1,043,110
DBVT
21
DBV Technologies
DBVT
$1.15B
$11M 1.38%
574,200
-443,821
EVMN
22
Evommune Inc
EVMN
$820M
$8.56M 1.07%
+500,000
DTIL icon
23
Precision BioSciences
DTIL
$101M
$7.98M 1%
+1,917,995
CRBP icon
24
Corbus Pharmaceuticals
CRBP
$150M
$7.77M 0.97%
955,000
-160,000
UNCY icon
25
Unicycive Therapeutics
UNCY
$149M
$5.77M 0.72%
1,000,000
1
2